CryoXtract Instruments, a developer of automation solutions for preserving and optimizing frozen biological samples, has obtained US patent covering systems, methods and devices for its frozen sample aliquotting technology.
Harvard University and Northeastern University collaborated on the development of the technology and jointly own the patent, while CryoXtract is the exclusive licensee.
Protecting the frozen biological samples from detrimental repeated freeze/thaw cycles, the patent also covers CryoXtract’s core technology and solutions that are used by researchers to access the samples.
CryoXtract CEO John McCarthy said frozen aliquotting can alter current sub-optimal practices for accessing and preserving the value of critical biosamples.
"Corresponding patent applications are pending in other international markets," McCarthy added.
"Additionally, we have filed new US and international patent applications directed to key enhancements and broadened applications for our core technology."
The company launched its CXT 350T Frozen Tissue Aliquotter system in early May 2013 for targeted, repeated and safe access to frozen tissue samples.